3,251 hedge funds and large institutions have $222B invested in Pfizer in 2021 Q4 according to their latest regulatory filings, with 586 funds opening new positions, 1,250 increasing their positions, 1,152 reducing their positions, and 85 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

9% more repeat investments, than reductions

Existing positions increased: 1,250 | Existing positions reduced: 1,152

1% more call options, than puts

Call options by funds: $5.34B | Put options by funds: $5.26B

0.97% more ownership

Funds ownership: 66.25%67.22% (+0.97%)

Holders
3,251
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
249
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.34B
Puts
$5.26B
Net Calls
Net Calls Change

Top Buyers

1 +$610M
2 +$609M
3 +$455M
4
JP Morgan Chase
JP Morgan Chase
New York
+$375M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$323M
Name Holding Trade Value Shares
Change
Change in
Stake
2501
$531K
2502
$531K
2503
$530K
2504
$530K
2505
$530K
2506
$529K
2507
$528K
2508
$527K
2509
$526K
2510
$526K
2511
$526K
2512
$521K
2513
$521K
2514
$520K
2515
$518K
2516
$517K
2517
$516K
2518
$515K
2519
$514K
2520
$514K
2521
$511K
2522
$511K
2523
$510K
2524
$508K
2525
$507K